Hematological cancer diseases
Showing 1 - 25 of >10,000
Hematologic Tumor, Tumors Trial in Gainesville, Baltimore, Houston (CC-486)
Active, not recruiting
- Hematologic Neoplasm
- Neoplasms
-
Gainesville, Florida
- +2 more
Jan 12, 2023
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,
Not yet recruiting
- Acute Myelogenous Leukemia
- +17 more
- Peripheral Blood Stem Cell Transplant
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Mar 27, 2023
Hematological Disorder Trial in Chapel Hill (Focus Group Discussions and Semi-structured Interviews, Training community lay
Not yet recruiting
- Hematological Disorder
- Focus Group Discussions and Semi-structured Interviews
- Training community lay navigators
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center, UNC
Apr 12, 2023
Prostate Infection, Prostate Disease, Prostate Cancer Trial in Istanbul (Serum PSA,Delta Neutrophil Index(DNI),WBC)
Completed
- Prostate Infection
- +2 more
- Serum PSA,Delta Neutrophil Index(DNI),WBC
-
Istanbul, TurkeyBasri Cakiroglu
May 31, 2022
GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)
Active, not recruiting
- Graft Versus Host Disease
- Hematopoietic/Lymphoid Cancer
- fludarabine phosphate
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Aug 5, 2022
Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases Trial in Suzhou (Umbilical Cord Blood Transplantation)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Malignant Hematological Diseases
- Umbilical Cord Blood Transplantation
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow university
Jul 3, 2023
Hematopoietic and Lymphoid Cell Tumor, Non-Neoplastic Hematologic and Lymphocytic Disorder Trial in United States (Supportive
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Non-Neoplastic Hematologic and Lymphocytic Disorder
- Supportive Palliative Care
- +6 more
-
Palo Alto, California
- +8 more
Jan 30, 2023
MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular
Recruiting
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- +8 more
-
Boston, Massachusetts
- +6 more
Apr 14, 2022
Children With Chronic Kidney Disease
Not yet recruiting
- CKD
- Hematological Disease
- (no location specified)
Nov 20, 2023
Hematological Disorder in Patients With Angiodysplasia
Not yet recruiting
- Angiodysplasia
- Hematological Disease
- Von willebrand antigen
- (no location specified)
Sep 26, 2023
Admission to the ICU of Onco-hematological Patients.
Not yet recruiting
- Hematological Diseases
- Critical Illness
- There is no intervention.
- (no location specified)
Nov 1, 2023
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation,
Recruiting
- Acute Myelogenous Leukemia
- +17 more
- Allopurinol
- +8 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
May 21, 2021
Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)
Recruiting
- Acute Leukemia
- +24 more
- Fludarabine
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 4, 2021
Acute Leukemia, Immune Deficiency Disorder, Congenital Hematological Disorder Trial in Rochester (radiation, drug, procedure)
Recruiting
- Acute Leukemia
- +9 more
- Total Body Irradiation 1200 cGy
- +7 more
-
Rochester, New YorkWilmot Cancer Institute
Jun 20, 2022
"Don't Eat me" Signal in Hematological Malignancies: CD24 as New
Recruiting
- Mantle-cell Lymphoma
- B Cell Chronic Lymphocytic Leukemia
-
Monza, MB, ItalyAndrea Aroldi
May 24, 2023
Hematological Malignancy Trial in Houston (Fludarabine Phosphate, Cyclophosphamide, CAR.5/IL15-transduced CB-NK cells)
Not yet recruiting
- Hematological Malignancy
- Fludarabine Phosphate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Hematological Disorders Associated With COVID-19 Infection
Completed
- Hematological Condition With COVID19
-
Assiut, EgyptFacility of medicine
Jan 6, 2023
Hematologic Malignancy, Muscle Weakness Trial in Istanbul (Neuromuscular Electrical Stimulation, Structured Exercise)
Completed
- Hematologic Malignancy
- Muscle Weakness
- Neuromuscular Electrical Stimulation
- Structured Exercise
-
Istanbul, TurkeyAcibadem University
May 25, 2022
Hematological Disease, Immune Deficiencies, Solid Tumors Trial in Rochester (radiation, drug, procedure)
Completed
- Hematological Disease
- +5 more
- Total Body Irradiation 1200 cGy
- +9 more
-
Rochester, New YorkWilmot Cancer Institute
Nov 1, 2021
SARS-CoV-2 (COVID-19) Infection, Advanced or Metastatic Hematological or Solid Tumor Trial in France (Autophagy inhibitor
Completed
- SARS-CoV-2 (COVID-19) Infection
- Advanced or Metastatic Hematological or Solid Tumor
- Autophagy inhibitor (GNS651)
- +3 more
-
Lyon, Rhône, France
- +11 more
Sep 29, 2022
Hematological Abnormalities in Children
Not yet recruiting
- Hematologic Diseases
- sampling
- (no location specified)
Sep 14, 2022
Hematologic Malignancy Trial in Tianjin (BR108 injection)
Recruiting
- Hematologic Malignancy
- BR108 injection
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Aug 25, 2023
Non-hodgkin's Lymphoma Trial in Beijing (GNC-035)
Not yet recruiting
- Non-hodgkin's Lymphoma
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Sep 27, 2023
Lymphoma, Leukemia, Myeloma Trial in Tampa (Resistance Training, Aerobic Exercise)
Recruiting
- Lymphoma
- +2 more
- Resistance Training
- Aerobic Exercise
-
Tampa, FloridaMoffitt Cancer Center
Feb 28, 2023
Cancer, Sleep Disturbance, Anxiety Trial in San Francisco (Calm Meditation, Health Education Podcast)
Not yet recruiting
- Cancer
- +5 more
- Calm Meditation
- Health Education Podcast
-
Phoenix, Arizona
- +1 more
Jan 11, 2023